These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29112517)

  • 1. Use of antidementia drugs in German patients with Alzheimer's disease.
    Hessmann P; Dodel R; Baum E; Müller MJ; Paschke G; Kis B; Zeidler J; Klora M; Reese JP; Balzer-Geldsetzer M
    Int Clin Psychopharmacol; 2018 Mar; 33(2):103-110. PubMed ID: 29112517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant medication in a German cohort of patients with Alzheimer's disease
.
    Hessmann P; Dodel R; Baum E; Müller MJ; Paschke G; Kis B; Zeidler J; Klora M; Reese JP; Balzer-Geldsetzer M
    Int J Clin Pharmacol Ther; 2018 Mar; 56(3):101-112. PubMed ID: 29350177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
    J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany.
    Hessmann P; Dodel R; Baum E; Müller MJ; Paschke G; Kis B; Zeidler J; Klora M; Reese JP; Balzer-Geldsetzer M
    Int J Psychiatry Clin Pract; 2018 Sep; 22(3):232-239. PubMed ID: 29235398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term progression of Alzheimer's disease in patients under antidementia drugs.
    Gillette-Guyonnet S; Andrieu S; Nourhashemi F; Gardette V; Coley N; Cantet C; Gauthier S; Ousset PJ; Vellas B;
    Alzheimers Dement; 2011 Nov; 7(6):579-92. PubMed ID: 22055975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.
    Heßmann P; Seeberg G; Reese JP; Dams J; Baum E; Müller MJ; Dodel R; Balzer-Geldsetzer M
    J Alzheimers Dis; 2016; 51(2):545-61. PubMed ID: 26890754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.
    Holthoff V; Ferris S; Gauthier S; Ihl R; Robert P; Winblad B; Sternberg K; Tennigkeit F;
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):164-72. PubMed ID: 22492589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).
    Matsuzono K; Yamashita T; Ohta Y; Hishikawa N; Koike M; Sato K; Kono S; Deguchi K; Nakano Y; Abe K
    J Alzheimers Dis; 2015; 47(2):487-93. PubMed ID: 26401570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
    Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
    J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different clinical effect of four antidementia drugs for Alzheimer's disease patients depending on white matter severity.
    Fukui Y; Hishikawa N; Ichinose J; Sato K; Nakano Y; Morihara R; Ohta Y; Yamashita T; Abe K
    Geriatr Gerontol Int; 2017 Nov; 17(11):1991-1999. PubMed ID: 28276131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.
    Lacey L; Bobula J; Rüdell K; Alvir J; Leibman C
    Value Health; 2015 Jul; 18(5):638-45. PubMed ID: 26297092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Errea JM; Rios C; Pina MA; Sarasa M
    Eur J Neurol; 2010 Mar; 17(3):405-12. PubMed ID: 19874395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of disease is different for cognitive and functional aspects in mild Alzheimer's disease: a one-year observation study.
    Sousa MF; Santos RL; Nogueira ML; Belfort T; Rosa RD; Torres B; Simões P; Mograbi DC; Laks J; Dourado MC
    J Alzheimers Dis; 2015; 43(3):905-13. PubMed ID: 25125460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
    Formiga F; Fort I; Robles MJ; Rodriguez D; Regalado P
    Dement Geriatr Cogn Disord; 2010; 29(3):198-203. PubMed ID: 20332637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription of Benzodiazepines and Related Drugs in Patients with Mild Cognitive Deficits and Alzheimer's Disease.
    Hessmann P; Dodel R; Baum E; Müller MJ; Paschke G; Kis B; Zeidler J; Klora M; Reese JP; Balzer-Geldsetzer M
    Pharmacopsychiatry; 2019 Feb; 52(2):84-91. PubMed ID: 29388173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.
    Koller D; Hua T; Bynum JP
    J Am Geriatr Soc; 2016 Aug; 64(8):1540-8. PubMed ID: 27341454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine in everyday clinical practice: a comparison of studies in Germany and Greece.
    Förstl H; Stamouli SS; Janetzky W; Galanopoulos A; Karageorgiou C; Tzanakaki M
    Dement Geriatr Cogn Disord; 2011; 32(4):267-72. PubMed ID: 22237255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I;
    JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
    Bullock R
    Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.